nodes	percent_of_prediction	percent_of_DWPC	metapath
Glycopyrrolate—CHRM3—epilepsy syndrome	0.239	0.371	CbGaD
Glycopyrrolate—CHRM1—epilepsy syndrome	0.223	0.346	CbGaD
Glycopyrrolate—CHRM2—epilepsy syndrome	0.182	0.283	CbGaD
Glycopyrrolate—Hexylcaine—SCN3A—epilepsy syndrome	0.000498	0.0681	CrCbGaD
Glycopyrrolate—CHRM4—head—epilepsy syndrome	0.000495	0.0605	CbGeAlD
Glycopyrrolate—CHRM4—nervous system—epilepsy syndrome	0.00047	0.0574	CbGeAlD
Glycopyrrolate—CHRM2—forebrain—epilepsy syndrome	0.000464	0.0567	CbGeAlD
Glycopyrrolate—CHRM4—central nervous system—epilepsy syndrome	0.000452	0.0552	CbGeAlD
Glycopyrrolate—CHRM2—telencephalon—epilepsy syndrome	0.000427	0.0521	CbGeAlD
Glycopyrrolate—CHRM1—forebrain—epilepsy syndrome	0.000422	0.0516	CbGeAlD
Glycopyrrolate—Cycrimine—CHRM1—epilepsy syndrome	0.000415	0.0567	CrCbGaD
Glycopyrrolate—CHRM1—telencephalon—epilepsy syndrome	0.000388	0.0475	CbGeAlD
Glycopyrrolate—CHRM5—head—epilepsy syndrome	0.000387	0.0473	CbGeAlD
Glycopyrrolate—CHRM3—forebrain—epilepsy syndrome	0.000378	0.0462	CbGeAlD
Glycopyrrolate—CHRM5—nervous system—epilepsy syndrome	0.000367	0.0448	CbGeAlD
Glycopyrrolate—CHRM4—brain—epilepsy syndrome	0.000359	0.0438	CbGeAlD
Glycopyrrolate—CHRM5—central nervous system—epilepsy syndrome	0.000353	0.0432	CbGeAlD
Glycopyrrolate—Oxyphenonium—CHRM3—epilepsy syndrome	0.000353	0.0483	CrCbGaD
Glycopyrrolate—Hexylcaine—SCN1A—epilepsy syndrome	0.00035	0.0478	CrCbGaD
Glycopyrrolate—CHRM3—telencephalon—epilepsy syndrome	0.000348	0.0425	CbGeAlD
Glycopyrrolate—Oxyphenonium—CHRM1—epilepsy syndrome	0.000329	0.0451	CrCbGaD
Glycopyrrolate—Hexylcaine—SCN2A—epilepsy syndrome	0.000308	0.0422	CrCbGaD
Glycopyrrolate—Oxyphencyclimine—CHRM3—epilepsy syndrome	0.0003	0.0411	CrCbGaD
Glycopyrrolate—CHRM5—brain—epilepsy syndrome	0.000281	0.0343	CbGeAlD
Glycopyrrolate—Oxyphencyclimine—CHRM1—epilepsy syndrome	0.00028	0.0383	CrCbGaD
Glycopyrrolate—CHRM2—head—epilepsy syndrome	0.000266	0.0325	CbGeAlD
Glycopyrrolate—Procyclidine—CHRM3—epilepsy syndrome	0.000255	0.0349	CrCbGaD
Glycopyrrolate—CHRM2—nervous system—epilepsy syndrome	0.000252	0.0308	CbGeAlD
Glycopyrrolate—Clidinium—CHRM3—epilepsy syndrome	0.000245	0.0335	CrCbGaD
Glycopyrrolate—CHRM2—central nervous system—epilepsy syndrome	0.000243	0.0296	CbGeAlD
Glycopyrrolate—CHRM1—head—epilepsy syndrome	0.000242	0.0295	CbGeAlD
Glycopyrrolate—Procyclidine—CHRM1—epilepsy syndrome	0.000238	0.0326	CrCbGaD
Glycopyrrolate—Trospium—CHRM3—epilepsy syndrome	0.000236	0.0322	CrCbGaD
Glycopyrrolate—Trihexyphenidyl—CHRM3—epilepsy syndrome	0.000234	0.0319	CrCbGaD
Glycopyrrolate—CHRM1—nervous system—epilepsy syndrome	0.000229	0.028	CbGeAlD
Glycopyrrolate—Oxyphencyclimine—CHRM2—epilepsy syndrome	0.000229	0.0313	CrCbGaD
Glycopyrrolate—Clidinium—CHRM1—epilepsy syndrome	0.000228	0.0312	CrCbGaD
Glycopyrrolate—CHRM1—central nervous system—epilepsy syndrome	0.000221	0.027	CbGeAlD
Glycopyrrolate—Trospium—CHRM1—epilepsy syndrome	0.00022	0.0301	CrCbGaD
Glycopyrrolate—Trihexyphenidyl—CHRM1—epilepsy syndrome	0.000218	0.0298	CrCbGaD
Glycopyrrolate—CHRM3—head—epilepsy syndrome	0.000216	0.0264	CbGeAlD
Glycopyrrolate—Oxybutynin—CHRM3—epilepsy syndrome	0.000214	0.0293	CrCbGaD
Glycopyrrolate—Homatropine Methylbromide—CHRM3—epilepsy syndrome	0.000208	0.0285	CrCbGaD
Glycopyrrolate—CHRM3—nervous system—epilepsy syndrome	0.000205	0.0251	CbGeAlD
Glycopyrrolate—Oxybutynin—CHRM1—epilepsy syndrome	0.0002	0.0273	CrCbGaD
Glycopyrrolate—CHRM3—central nervous system—epilepsy syndrome	0.000198	0.0241	CbGeAlD
Glycopyrrolate—Mepenzolate—CHRM3—epilepsy syndrome	0.000197	0.0269	CrCbGaD
Glycopyrrolate—Procyclidine—CHRM2—epilepsy syndrome	0.000194	0.0266	CrCbGaD
Glycopyrrolate—Homatropine Methylbromide—CHRM1—epilepsy syndrome	0.000194	0.0266	CrCbGaD
Glycopyrrolate—CHRM2—brain—epilepsy syndrome	0.000193	0.0235	CbGeAlD
Glycopyrrolate—Mepenzolate—CHRM1—epilepsy syndrome	0.000184	0.0251	CrCbGaD
Glycopyrrolate—Trospium—CHRM2—epilepsy syndrome	0.000179	0.0245	CrCbGaD
Glycopyrrolate—Trihexyphenidyl—CHRM2—epilepsy syndrome	0.000178	0.0243	CrCbGaD
Glycopyrrolate—CHRM1—brain—epilepsy syndrome	0.000175	0.0214	CbGeAlD
Glycopyrrolate—Oxybutynin—CHRM2—epilepsy syndrome	0.000163	0.0223	CrCbGaD
Glycopyrrolate—Homatropine Methylbromide—CHRM2—epilepsy syndrome	0.000159	0.0217	CrCbGaD
Glycopyrrolate—CHRM3—brain—epilepsy syndrome	0.000157	0.0192	CbGeAlD
Glycopyrrolate—Mepenzolate—CHRM2—epilepsy syndrome	0.00015	0.0205	CrCbGaD
Glycopyrrolate—Trospium—CYP2D6—epilepsy syndrome	8.21e-05	0.0112	CrCbGaD
Glycopyrrolate—Abdominal pain—Carbamazepine—epilepsy syndrome	8.14e-05	0.000358	CcSEcCtD
Glycopyrrolate—Body temperature increased—Carbamazepine—epilepsy syndrome	8.14e-05	0.000358	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Lamotrigine—epilepsy syndrome	8.14e-05	0.000358	CcSEcCtD
Glycopyrrolate—Sinusitis—Topiramate—epilepsy syndrome	8.12e-05	0.000356	CcSEcCtD
Glycopyrrolate—Rash—Levetiracetam—epilepsy syndrome	8.1e-05	0.000356	CcSEcCtD
Glycopyrrolate—Dermatitis—Levetiracetam—epilepsy syndrome	8.09e-05	0.000355	CcSEcCtD
Glycopyrrolate—Asthenia—Zonisamide—epilepsy syndrome	8.09e-05	0.000355	CcSEcCtD
Glycopyrrolate—Mental disorder—Gabapentin—epilepsy syndrome	8.09e-05	0.000355	CcSEcCtD
Glycopyrrolate—Dry mouth—Valproic Acid—epilepsy syndrome	8.07e-05	0.000354	CcSEcCtD
Glycopyrrolate—Agitation—Pregabalin—epilepsy syndrome	8.05e-05	0.000354	CcSEcCtD
Glycopyrrolate—Headache—Levetiracetam—epilepsy syndrome	8.05e-05	0.000353	CcSEcCtD
Glycopyrrolate—Erythema—Gabapentin—epilepsy syndrome	8.04e-05	0.000353	CcSEcCtD
Glycopyrrolate—Malnutrition—Gabapentin—epilepsy syndrome	8.04e-05	0.000353	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Clonazepam—epilepsy syndrome	8.01e-05	0.000352	CcSEcCtD
Glycopyrrolate—Dizziness—Vigabatrin—epilepsy syndrome	7.99e-05	0.000351	CcSEcCtD
Glycopyrrolate—Confusional state—Valproic Acid—epilepsy syndrome	7.98e-05	0.00035	CcSEcCtD
Glycopyrrolate—Pruritus—Zonisamide—epilepsy syndrome	7.98e-05	0.00035	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Phenytoin—epilepsy syndrome	7.95e-05	0.000349	CcSEcCtD
Glycopyrrolate—Flatulence—Gabapentin—epilepsy syndrome	7.92e-05	0.000348	CcSEcCtD
Glycopyrrolate—Oedema—Valproic Acid—epilepsy syndrome	7.91e-05	0.000347	CcSEcCtD
Glycopyrrolate—Anaphylactic shock—Valproic Acid—epilepsy syndrome	7.91e-05	0.000347	CcSEcCtD
Glycopyrrolate—Urticaria—Lamotrigine—epilepsy syndrome	7.91e-05	0.000347	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	7.91e-05	0.000347	CcSEcCtD
Glycopyrrolate—Nausea—Propofol—epilepsy syndrome	7.9e-05	0.000347	CcSEcCtD
Glycopyrrolate—Tension—Gabapentin—epilepsy syndrome	7.89e-05	0.000346	CcSEcCtD
Glycopyrrolate—Vomiting—Fosphenytoin—epilepsy syndrome	7.88e-05	0.000346	CcSEcCtD
Glycopyrrolate—Body temperature increased—Lamotrigine—epilepsy syndrome	7.87e-05	0.000346	CcSEcCtD
Glycopyrrolate—Abdominal pain—Lamotrigine—epilepsy syndrome	7.87e-05	0.000346	CcSEcCtD
Glycopyrrolate—Dysgeusia—Gabapentin—epilepsy syndrome	7.87e-05	0.000346	CcSEcCtD
Glycopyrrolate—Dizziness—Diazepam—epilepsy syndrome	7.87e-05	0.000346	CcSEcCtD
Glycopyrrolate—Infection—Valproic Acid—epilepsy syndrome	7.86e-05	0.000345	CcSEcCtD
Glycopyrrolate—Rash—Fosphenytoin—epilepsy syndrome	7.82e-05	0.000343	CcSEcCtD
Glycopyrrolate—Dermatitis—Fosphenytoin—epilepsy syndrome	7.81e-05	0.000343	CcSEcCtD
Glycopyrrolate—Nervousness—Gabapentin—epilepsy syndrome	7.81e-05	0.000343	CcSEcCtD
Glycopyrrolate—Asthenia—Clonazepam—epilepsy syndrome	7.8e-05	0.000342	CcSEcCtD
Glycopyrrolate—Rhinitis—Topiramate—epilepsy syndrome	7.79e-05	0.000342	CcSEcCtD
Glycopyrrolate—Headache—Fosphenytoin—epilepsy syndrome	7.77e-05	0.000341	CcSEcCtD
Glycopyrrolate—Nervous system disorder—Valproic Acid—epilepsy syndrome	7.76e-05	0.000341	CcSEcCtD
Glycopyrrolate—Palpitations—Pregabalin—epilepsy syndrome	7.75e-05	0.00034	CcSEcCtD
Glycopyrrolate—Asthenia—Phenytoin—epilepsy syndrome	7.74e-05	0.00034	CcSEcCtD
Glycopyrrolate—Nausea—Midazolam—epilepsy syndrome	7.73e-05	0.000339	CcSEcCtD
Glycopyrrolate—Hypoaesthesia—Topiramate—epilepsy syndrome	7.73e-05	0.000339	CcSEcCtD
Glycopyrrolate—Tachycardia—Valproic Acid—epilepsy syndrome	7.72e-05	0.000339	CcSEcCtD
Glycopyrrolate—Asthenia—Oxcarbazepine—epilepsy syndrome	7.7e-05	0.000338	CcSEcCtD
Glycopyrrolate—Pruritus—Clonazepam—epilepsy syndrome	7.69e-05	0.000338	CcSEcCtD
Glycopyrrolate—Vomiting—Vigabatrin—epilepsy syndrome	7.69e-05	0.000337	CcSEcCtD
Glycopyrrolate—Skin disorder—Valproic Acid—epilepsy syndrome	7.69e-05	0.000337	CcSEcCtD
Glycopyrrolate—Urinary tract disorder—Topiramate—epilepsy syndrome	7.67e-05	0.000337	CcSEcCtD
Glycopyrrolate—Hyperhidrosis—Valproic Acid—epilepsy syndrome	7.65e-05	0.000336	CcSEcCtD
Glycopyrrolate—Pruritus—Phenytoin—epilepsy syndrome	7.64e-05	0.000335	CcSEcCtD
Glycopyrrolate—Connective tissue disorder—Topiramate—epilepsy syndrome	7.63e-05	0.000335	CcSEcCtD
Glycopyrrolate—Nausea—Levetiracetam—epilepsy syndrome	7.63e-05	0.000335	CcSEcCtD
Glycopyrrolate—Rash—Vigabatrin—epilepsy syndrome	7.62e-05	0.000335	CcSEcCtD
Glycopyrrolate—Dizziness—Felbamate—epilepsy syndrome	7.62e-05	0.000334	CcSEcCtD
Glycopyrrolate—Dermatitis—Vigabatrin—epilepsy syndrome	7.61e-05	0.000334	CcSEcCtD
Glycopyrrolate—Urethral disorder—Topiramate—epilepsy syndrome	7.61e-05	0.000334	CcSEcCtD
Glycopyrrolate—Pruritus—Oxcarbazepine—epilepsy syndrome	7.6e-05	0.000334	CcSEcCtD
Glycopyrrolate—Convulsion—Pregabalin—epilepsy syndrome	7.59e-05	0.000333	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Carbamazepine—epilepsy syndrome	7.59e-05	0.000333	CcSEcCtD
Glycopyrrolate—Vision blurred—Gabapentin—epilepsy syndrome	7.57e-05	0.000333	CcSEcCtD
Glycopyrrolate—Headache—Vigabatrin—epilepsy syndrome	7.57e-05	0.000333	CcSEcCtD
Glycopyrrolate—Hypertension—Pregabalin—epilepsy syndrome	7.57e-05	0.000332	CcSEcCtD
Glycopyrrolate—Vomiting—Diazepam—epilepsy syndrome	7.57e-05	0.000332	CcSEcCtD
Glycopyrrolate—Rash—Diazepam—epilepsy syndrome	7.5e-05	0.000329	CcSEcCtD
Glycopyrrolate—Dermatitis—Diazepam—epilepsy syndrome	7.5e-05	0.000329	CcSEcCtD
Glycopyrrolate—Oxybutynin—CYP2D6—epilepsy syndrome	7.46e-05	0.0102	CrCbGaD
Glycopyrrolate—Dizziness—Zonisamide—epilepsy syndrome	7.46e-05	0.000327	CcSEcCtD
Glycopyrrolate—Headache—Diazepam—epilepsy syndrome	7.46e-05	0.000327	CcSEcCtD
Glycopyrrolate—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	7.41e-05	0.000325	CcSEcCtD
Glycopyrrolate—Hypotension—Valproic Acid—epilepsy syndrome	7.39e-05	0.000325	CcSEcCtD
Glycopyrrolate—Asthenia—Carbamazepine—epilepsy syndrome	7.39e-05	0.000325	CcSEcCtD
Glycopyrrolate—Agitation—Gabapentin—epilepsy syndrome	7.39e-05	0.000324	CcSEcCtD
Glycopyrrolate—Nausea—Fosphenytoin—epilepsy syndrome	7.37e-05	0.000323	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Lamotrigine—epilepsy syndrome	7.34e-05	0.000322	CcSEcCtD
Glycopyrrolate—Vomiting—Felbamate—epilepsy syndrome	7.32e-05	0.000322	CcSEcCtD
Glycopyrrolate—Dry mouth—Pregabalin—epilepsy syndrome	7.3e-05	0.00032	CcSEcCtD
Glycopyrrolate—Pruritus—Carbamazepine—epilepsy syndrome	7.29e-05	0.00032	CcSEcCtD
Glycopyrrolate—Rash—Felbamate—epilepsy syndrome	7.26e-05	0.000319	CcSEcCtD
Glycopyrrolate—Dermatitis—Felbamate—epilepsy syndrome	7.26e-05	0.000319	CcSEcCtD
Glycopyrrolate—Headache—Felbamate—epilepsy syndrome	7.22e-05	0.000317	CcSEcCtD
Glycopyrrolate—Confusional state—Pregabalin—epilepsy syndrome	7.21e-05	0.000317	CcSEcCtD
Glycopyrrolate—Flushing—Topiramate—epilepsy syndrome	7.21e-05	0.000317	CcSEcCtD
Glycopyrrolate—Cardiac disorder—Topiramate—epilepsy syndrome	7.21e-05	0.000317	CcSEcCtD
Glycopyrrolate—Dizziness—Clonazepam—epilepsy syndrome	7.19e-05	0.000316	CcSEcCtD
Glycopyrrolate—Nausea—Vigabatrin—epilepsy syndrome	7.18e-05	0.000315	CcSEcCtD
Glycopyrrolate—Vomiting—Zonisamide—epilepsy syndrome	7.17e-05	0.000315	CcSEcCtD
Glycopyrrolate—Insomnia—Valproic Acid—epilepsy syndrome	7.16e-05	0.000314	CcSEcCtD
Glycopyrrolate—Anaphylactic shock—Pregabalin—epilepsy syndrome	7.15e-05	0.000314	CcSEcCtD
Glycopyrrolate—Oedema—Pregabalin—epilepsy syndrome	7.15e-05	0.000314	CcSEcCtD
Glycopyrrolate—Asthenia—Lamotrigine—epilepsy syndrome	7.14e-05	0.000314	CcSEcCtD
Glycopyrrolate—Dizziness—Phenytoin—epilepsy syndrome	7.14e-05	0.000313	CcSEcCtD
Glycopyrrolate—Rash—Zonisamide—epilepsy syndrome	7.11e-05	0.000312	CcSEcCtD
Glycopyrrolate—Infection—Pregabalin—epilepsy syndrome	7.11e-05	0.000312	CcSEcCtD
Glycopyrrolate—Palpitations—Gabapentin—epilepsy syndrome	7.1e-05	0.000312	CcSEcCtD
Glycopyrrolate—Dermatitis—Zonisamide—epilepsy syndrome	7.1e-05	0.000312	CcSEcCtD
Glycopyrrolate—Dizziness—Oxcarbazepine—epilepsy syndrome	7.1e-05	0.000312	CcSEcCtD
Glycopyrrolate—Nausea—Diazepam—epilepsy syndrome	7.07e-05	0.00031	CcSEcCtD
Glycopyrrolate—Headache—Zonisamide—epilepsy syndrome	7.06e-05	0.00031	CcSEcCtD
Glycopyrrolate—Pruritus—Lamotrigine—epilepsy syndrome	7.04e-05	0.000309	CcSEcCtD
Glycopyrrolate—Somnolence—Valproic Acid—epilepsy syndrome	7.03e-05	0.000309	CcSEcCtD
Glycopyrrolate—Nervous system disorder—Pregabalin—epilepsy syndrome	7.01e-05	0.000308	CcSEcCtD
Glycopyrrolate—Mediastinal disorder—Topiramate—epilepsy syndrome	7e-05	0.000307	CcSEcCtD
Glycopyrrolate—Tachycardia—Pregabalin—epilepsy syndrome	6.98e-05	0.000307	CcSEcCtD
Glycopyrrolate—Dyspepsia—Valproic Acid—epilepsy syndrome	6.96e-05	0.000306	CcSEcCtD
Glycopyrrolate—Convulsion—Gabapentin—epilepsy syndrome	6.96e-05	0.000306	CcSEcCtD
Glycopyrrolate—Skin disorder—Pregabalin—epilepsy syndrome	6.95e-05	0.000305	CcSEcCtD
Glycopyrrolate—Hypertension—Gabapentin—epilepsy syndrome	6.94e-05	0.000305	CcSEcCtD
Glycopyrrolate—Hyperhidrosis—Pregabalin—epilepsy syndrome	6.91e-05	0.000304	CcSEcCtD
Glycopyrrolate—Vomiting—Clonazepam—epilepsy syndrome	6.91e-05	0.000303	CcSEcCtD
Glycopyrrolate—Vomiting—Phenytoin—epilepsy syndrome	6.86e-05	0.000301	CcSEcCtD
Glycopyrrolate—Rash—Clonazepam—epilepsy syndrome	6.85e-05	0.000301	CcSEcCtD
Glycopyrrolate—Dermatitis—Clonazepam—epilepsy syndrome	6.84e-05	0.000301	CcSEcCtD
Glycopyrrolate—Nausea—Felbamate—epilepsy syndrome	6.84e-05	0.0003	CcSEcCtD
Glycopyrrolate—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	6.83e-05	0.0003	CcSEcCtD
Glycopyrrolate—Vomiting—Oxcarbazepine—epilepsy syndrome	6.83e-05	0.0003	CcSEcCtD
Glycopyrrolate—Fatigue—Valproic Acid—epilepsy syndrome	6.82e-05	0.0003	CcSEcCtD
Glycopyrrolate—Dizziness—Carbamazepine—epilepsy syndrome	6.81e-05	0.000299	CcSEcCtD
Glycopyrrolate—Headache—Clonazepam—epilepsy syndrome	6.81e-05	0.000299	CcSEcCtD
Glycopyrrolate—Rash—Phenytoin—epilepsy syndrome	6.81e-05	0.000299	CcSEcCtD
Glycopyrrolate—Mental disorder—Topiramate—epilepsy syndrome	6.8e-05	0.000299	CcSEcCtD
Glycopyrrolate—Dermatitis—Phenytoin—epilepsy syndrome	6.8e-05	0.000299	CcSEcCtD
Glycopyrrolate—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	6.79e-05	0.000298	CcSEcCtD
Glycopyrrolate—Rash—Oxcarbazepine—epilepsy syndrome	6.77e-05	0.000297	CcSEcCtD
Glycopyrrolate—Pain—Valproic Acid—epilepsy syndrome	6.77e-05	0.000297	CcSEcCtD
Glycopyrrolate—Constipation—Valproic Acid—epilepsy syndrome	6.77e-05	0.000297	CcSEcCtD
Glycopyrrolate—Dermatitis—Oxcarbazepine—epilepsy syndrome	6.76e-05	0.000297	CcSEcCtD
Glycopyrrolate—Headache—Phenytoin—epilepsy syndrome	6.76e-05	0.000297	CcSEcCtD
Glycopyrrolate—Erythema—Topiramate—epilepsy syndrome	6.76e-05	0.000297	CcSEcCtD
Glycopyrrolate—Malnutrition—Topiramate—epilepsy syndrome	6.76e-05	0.000297	CcSEcCtD
Glycopyrrolate—Headache—Oxcarbazepine—epilepsy syndrome	6.73e-05	0.000295	CcSEcCtD
Glycopyrrolate—Nausea—Zonisamide—epilepsy syndrome	6.7e-05	0.000294	CcSEcCtD
Glycopyrrolate—Dry mouth—Gabapentin—epilepsy syndrome	6.69e-05	0.000294	CcSEcCtD
Glycopyrrolate—Hypotension—Pregabalin—epilepsy syndrome	6.68e-05	0.000294	CcSEcCtD
Glycopyrrolate—Flatulence—Topiramate—epilepsy syndrome	6.66e-05	0.000293	CcSEcCtD
Glycopyrrolate—Tension—Topiramate—epilepsy syndrome	6.63e-05	0.000291	CcSEcCtD
Glycopyrrolate—Dysgeusia—Topiramate—epilepsy syndrome	6.62e-05	0.000291	CcSEcCtD
Glycopyrrolate—Confusional state—Gabapentin—epilepsy syndrome	6.61e-05	0.00029	CcSEcCtD
Glycopyrrolate—Dizziness—Lamotrigine—epilepsy syndrome	6.58e-05	0.000289	CcSEcCtD
Glycopyrrolate—Nervousness—Topiramate—epilepsy syndrome	6.57e-05	0.000288	CcSEcCtD
Glycopyrrolate—Anaphylactic shock—Gabapentin—epilepsy syndrome	6.56e-05	0.000288	CcSEcCtD
Glycopyrrolate—Oedema—Gabapentin—epilepsy syndrome	6.56e-05	0.000288	CcSEcCtD
Glycopyrrolate—Vomiting—Carbamazepine—epilepsy syndrome	6.55e-05	0.000288	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Valproic Acid—epilepsy syndrome	6.52e-05	0.000286	CcSEcCtD
Glycopyrrolate—Infection—Gabapentin—epilepsy syndrome	6.52e-05	0.000286	CcSEcCtD
Glycopyrrolate—Rash—Carbamazepine—epilepsy syndrome	6.5e-05	0.000285	CcSEcCtD
Glycopyrrolate—Dermatitis—Carbamazepine—epilepsy syndrome	6.49e-05	0.000285	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	6.47e-05	0.000284	CcSEcCtD
Glycopyrrolate—Insomnia—Pregabalin—epilepsy syndrome	6.47e-05	0.000284	CcSEcCtD
Glycopyrrolate—Nausea—Clonazepam—epilepsy syndrome	6.45e-05	0.000283	CcSEcCtD
Glycopyrrolate—Headache—Carbamazepine—epilepsy syndrome	6.45e-05	0.000283	CcSEcCtD
Glycopyrrolate—Nervous system disorder—Gabapentin—epilepsy syndrome	6.43e-05	0.000282	CcSEcCtD
Glycopyrrolate—Nausea—Phenytoin—epilepsy syndrome	6.41e-05	0.000282	CcSEcCtD
Glycopyrrolate—Tachycardia—Gabapentin—epilepsy syndrome	6.4e-05	0.000281	CcSEcCtD
Glycopyrrolate—Nausea—Oxcarbazepine—epilepsy syndrome	6.38e-05	0.00028	CcSEcCtD
Glycopyrrolate—Vision blurred—Topiramate—epilepsy syndrome	6.37e-05	0.00028	CcSEcCtD
Glycopyrrolate—Skin disorder—Gabapentin—epilepsy syndrome	6.37e-05	0.00028	CcSEcCtD
Glycopyrrolate—Somnolence—Pregabalin—epilepsy syndrome	6.36e-05	0.000279	CcSEcCtD
Glycopyrrolate—Hyperhidrosis—Gabapentin—epilepsy syndrome	6.34e-05	0.000278	CcSEcCtD
Glycopyrrolate—Vomiting—Lamotrigine—epilepsy syndrome	6.33e-05	0.000278	CcSEcCtD
Glycopyrrolate—Urticaria—Valproic Acid—epilepsy syndrome	6.29e-05	0.000276	CcSEcCtD
Glycopyrrolate—Rash—Lamotrigine—epilepsy syndrome	6.28e-05	0.000276	CcSEcCtD
Glycopyrrolate—Dermatitis—Lamotrigine—epilepsy syndrome	6.27e-05	0.000275	CcSEcCtD
Glycopyrrolate—Body temperature increased—Valproic Acid—epilepsy syndrome	6.25e-05	0.000275	CcSEcCtD
Glycopyrrolate—Abdominal pain—Valproic Acid—epilepsy syndrome	6.25e-05	0.000275	CcSEcCtD
Glycopyrrolate—Headache—Lamotrigine—epilepsy syndrome	6.24e-05	0.000274	CcSEcCtD
Glycopyrrolate—Agitation—Topiramate—epilepsy syndrome	6.21e-05	0.000273	CcSEcCtD
Glycopyrrolate—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	6.18e-05	0.000271	CcSEcCtD
Glycopyrrolate—Fatigue—Pregabalin—epilepsy syndrome	6.17e-05	0.000271	CcSEcCtD
Glycopyrrolate—Hypotension—Gabapentin—epilepsy syndrome	6.13e-05	0.000269	CcSEcCtD
Glycopyrrolate—Nausea—Carbamazepine—epilepsy syndrome	6.12e-05	0.000269	CcSEcCtD
Glycopyrrolate—Pain—Pregabalin—epilepsy syndrome	6.12e-05	0.000269	CcSEcCtD
Glycopyrrolate—Constipation—Pregabalin—epilepsy syndrome	6.12e-05	0.000269	CcSEcCtD
Glycopyrrolate—Palpitations—Topiramate—epilepsy syndrome	5.98e-05	0.000262	CcSEcCtD
Glycopyrrolate—Insomnia—Gabapentin—epilepsy syndrome	5.93e-05	0.000261	CcSEcCtD
Glycopyrrolate—Nausea—Lamotrigine—epilepsy syndrome	5.91e-05	0.00026	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Pregabalin—epilepsy syndrome	5.89e-05	0.000259	CcSEcCtD
Glycopyrrolate—Convulsion—Topiramate—epilepsy syndrome	5.86e-05	0.000257	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Pregabalin—epilepsy syndrome	5.85e-05	0.000257	CcSEcCtD
Glycopyrrolate—Hypertension—Topiramate—epilepsy syndrome	5.84e-05	0.000256	CcSEcCtD
Glycopyrrolate—Somnolence—Gabapentin—epilepsy syndrome	5.83e-05	0.000256	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Valproic Acid—epilepsy syndrome	5.83e-05	0.000256	CcSEcCtD
Glycopyrrolate—Dyspepsia—Gabapentin—epilepsy syndrome	5.77e-05	0.000254	CcSEcCtD
Glycopyrrolate—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	5.72e-05	0.000251	CcSEcCtD
Glycopyrrolate—Urticaria—Pregabalin—epilepsy syndrome	5.68e-05	0.00025	CcSEcCtD
Glycopyrrolate—Asthenia—Valproic Acid—epilepsy syndrome	5.68e-05	0.000249	CcSEcCtD
Glycopyrrolate—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	5.66e-05	0.000249	CcSEcCtD
Glycopyrrolate—Fatigue—Gabapentin—epilepsy syndrome	5.65e-05	0.000248	CcSEcCtD
Glycopyrrolate—Abdominal pain—Pregabalin—epilepsy syndrome	5.65e-05	0.000248	CcSEcCtD
Glycopyrrolate—Body temperature increased—Pregabalin—epilepsy syndrome	5.65e-05	0.000248	CcSEcCtD
Glycopyrrolate—Dry mouth—Topiramate—epilepsy syndrome	5.63e-05	0.000247	CcSEcCtD
Glycopyrrolate—Constipation—Gabapentin—epilepsy syndrome	5.61e-05	0.000246	CcSEcCtD
Glycopyrrolate—Pain—Gabapentin—epilepsy syndrome	5.61e-05	0.000246	CcSEcCtD
Glycopyrrolate—Pruritus—Valproic Acid—epilepsy syndrome	5.6e-05	0.000246	CcSEcCtD
Glycopyrrolate—Confusional state—Topiramate—epilepsy syndrome	5.56e-05	0.000244	CcSEcCtD
Glycopyrrolate—Oedema—Topiramate—epilepsy syndrome	5.52e-05	0.000242	CcSEcCtD
Glycopyrrolate—Infection—Topiramate—epilepsy syndrome	5.48e-05	0.000241	CcSEcCtD
Glycopyrrolate—Nervous system disorder—Topiramate—epilepsy syndrome	5.41e-05	0.000238	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Gabapentin—epilepsy syndrome	5.41e-05	0.000237	CcSEcCtD
Glycopyrrolate—Tachycardia—Topiramate—epilepsy syndrome	5.39e-05	0.000236	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Gabapentin—epilepsy syndrome	5.36e-05	0.000236	CcSEcCtD
Glycopyrrolate—Skin disorder—Topiramate—epilepsy syndrome	5.36e-05	0.000235	CcSEcCtD
Glycopyrrolate—Hyperhidrosis—Topiramate—epilepsy syndrome	5.33e-05	0.000234	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Pregabalin—epilepsy syndrome	5.27e-05	0.000231	CcSEcCtD
Glycopyrrolate—Dizziness—Valproic Acid—epilepsy syndrome	5.23e-05	0.00023	CcSEcCtD
Glycopyrrolate—Urticaria—Gabapentin—epilepsy syndrome	5.21e-05	0.000229	CcSEcCtD
Glycopyrrolate—Abdominal pain—Gabapentin—epilepsy syndrome	5.19e-05	0.000228	CcSEcCtD
Glycopyrrolate—Body temperature increased—Gabapentin—epilepsy syndrome	5.19e-05	0.000228	CcSEcCtD
Glycopyrrolate—Hypotension—Topiramate—epilepsy syndrome	5.16e-05	0.000226	CcSEcCtD
Glycopyrrolate—Asthenia—Pregabalin—epilepsy syndrome	5.13e-05	0.000225	CcSEcCtD
Glycopyrrolate—Pruritus—Pregabalin—epilepsy syndrome	5.06e-05	0.000222	CcSEcCtD
Glycopyrrolate—Vomiting—Valproic Acid—epilepsy syndrome	5.03e-05	0.000221	CcSEcCtD
Glycopyrrolate—Insomnia—Topiramate—epilepsy syndrome	4.99e-05	0.000219	CcSEcCtD
Glycopyrrolate—Rash—Valproic Acid—epilepsy syndrome	4.99e-05	0.000219	CcSEcCtD
Glycopyrrolate—Dermatitis—Valproic Acid—epilepsy syndrome	4.98e-05	0.000219	CcSEcCtD
Glycopyrrolate—Headache—Valproic Acid—epilepsy syndrome	4.96e-05	0.000218	CcSEcCtD
Glycopyrrolate—Somnolence—Topiramate—epilepsy syndrome	4.91e-05	0.000215	CcSEcCtD
Glycopyrrolate—Dyspepsia—Topiramate—epilepsy syndrome	4.86e-05	0.000213	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Gabapentin—epilepsy syndrome	4.83e-05	0.000212	CcSEcCtD
Glycopyrrolate—Gastrointestinal disorder—Topiramate—epilepsy syndrome	4.76e-05	0.000209	CcSEcCtD
Glycopyrrolate—Fatigue—Topiramate—epilepsy syndrome	4.76e-05	0.000209	CcSEcCtD
Glycopyrrolate—Dizziness—Pregabalin—epilepsy syndrome	4.73e-05	0.000208	CcSEcCtD
Glycopyrrolate—Constipation—Topiramate—epilepsy syndrome	4.72e-05	0.000207	CcSEcCtD
Glycopyrrolate—Pain—Topiramate—epilepsy syndrome	4.72e-05	0.000207	CcSEcCtD
Glycopyrrolate—Asthenia—Gabapentin—epilepsy syndrome	4.71e-05	0.000207	CcSEcCtD
Glycopyrrolate—Nausea—Valproic Acid—epilepsy syndrome	4.7e-05	0.000206	CcSEcCtD
Glycopyrrolate—Pruritus—Gabapentin—epilepsy syndrome	4.64e-05	0.000204	CcSEcCtD
Glycopyrrolate—Vomiting—Pregabalin—epilepsy syndrome	4.55e-05	0.0002	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Topiramate—epilepsy syndrome	4.55e-05	0.0002	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Topiramate—epilepsy syndrome	4.51e-05	0.000198	CcSEcCtD
Glycopyrrolate—Rash—Pregabalin—epilepsy syndrome	4.51e-05	0.000198	CcSEcCtD
Glycopyrrolate—Dermatitis—Pregabalin—epilepsy syndrome	4.51e-05	0.000198	CcSEcCtD
Glycopyrrolate—Headache—Pregabalin—epilepsy syndrome	4.48e-05	0.000197	CcSEcCtD
Glycopyrrolate—Urticaria—Topiramate—epilepsy syndrome	4.38e-05	0.000192	CcSEcCtD
Glycopyrrolate—Abdominal pain—Topiramate—epilepsy syndrome	4.36e-05	0.000192	CcSEcCtD
Glycopyrrolate—Body temperature increased—Topiramate—epilepsy syndrome	4.36e-05	0.000192	CcSEcCtD
Glycopyrrolate—Dizziness—Gabapentin—epilepsy syndrome	4.34e-05	0.00019	CcSEcCtD
Glycopyrrolate—Nausea—Pregabalin—epilepsy syndrome	4.25e-05	0.000187	CcSEcCtD
Glycopyrrolate—Vomiting—Gabapentin—epilepsy syndrome	4.17e-05	0.000183	CcSEcCtD
Glycopyrrolate—Rash—Gabapentin—epilepsy syndrome	4.14e-05	0.000182	CcSEcCtD
Glycopyrrolate—Dermatitis—Gabapentin—epilepsy syndrome	4.13e-05	0.000181	CcSEcCtD
Glycopyrrolate—Headache—Gabapentin—epilepsy syndrome	4.11e-05	0.00018	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Topiramate—epilepsy syndrome	4.07e-05	0.000179	CcSEcCtD
Glycopyrrolate—Asthenia—Topiramate—epilepsy syndrome	3.96e-05	0.000174	CcSEcCtD
Glycopyrrolate—Pruritus—Topiramate—epilepsy syndrome	3.9e-05	0.000171	CcSEcCtD
Glycopyrrolate—Nausea—Gabapentin—epilepsy syndrome	3.9e-05	0.000171	CcSEcCtD
Glycopyrrolate—Dizziness—Topiramate—epilepsy syndrome	3.65e-05	0.00016	CcSEcCtD
Glycopyrrolate—Vomiting—Topiramate—epilepsy syndrome	3.51e-05	0.000154	CcSEcCtD
Glycopyrrolate—Rash—Topiramate—epilepsy syndrome	3.48e-05	0.000153	CcSEcCtD
Glycopyrrolate—Dermatitis—Topiramate—epilepsy syndrome	3.48e-05	0.000153	CcSEcCtD
Glycopyrrolate—Headache—Topiramate—epilepsy syndrome	3.46e-05	0.000152	CcSEcCtD
Glycopyrrolate—Nausea—Topiramate—epilepsy syndrome	3.28e-05	0.000144	CcSEcCtD
Glycopyrrolate—CHRM1—Signaling Pathways—CCL3—epilepsy syndrome	8.83e-06	7.85e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—HSPB1—epilepsy syndrome	8.8e-06	7.82e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—CRH—epilepsy syndrome	8.8e-06	7.82e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—CXCL2—epilepsy syndrome	8.8e-06	7.82e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—OXT—epilepsy syndrome	8.8e-06	7.82e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—CCL3—epilepsy syndrome	8.8e-06	7.82e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR downstream signaling—AGT—epilepsy syndrome	8.79e-06	7.81e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—PLCB1—epilepsy syndrome	8.75e-06	7.78e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—TH—epilepsy syndrome	8.72e-06	7.75e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—CCL3—epilepsy syndrome	8.72e-06	7.75e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—CRH—epilepsy syndrome	8.72e-06	7.75e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—HSPB1—epilepsy syndrome	8.72e-06	7.75e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—CXCL2—epilepsy syndrome	8.72e-06	7.75e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—OXT—epilepsy syndrome	8.72e-06	7.75e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—CCR5—epilepsy syndrome	8.71e-06	7.74e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—CCR5—epilepsy syndrome	8.68e-06	7.72e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—CCR5—epilepsy syndrome	8.6e-06	7.64e-05	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—AVP—epilepsy syndrome	8.59e-06	7.64e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—HTR2A—epilepsy syndrome	8.52e-06	7.58e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—HTR2A—epilepsy syndrome	8.5e-06	7.55e-05	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—HES1—epilepsy syndrome	8.49e-06	7.54e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—HTR2A—epilepsy syndrome	8.41e-06	7.48e-05	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—FYN—epilepsy syndrome	8.25e-06	7.34e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR downstream signaling—PRKCB—epilepsy syndrome	8.23e-06	7.31e-05	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—H2AFX—epilepsy syndrome	8.22e-06	7.31e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—TSC1—epilepsy syndrome	8.21e-06	7.3e-05	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—MEF2C—epilepsy syndrome	8.21e-06	7.3e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—PTK2B—epilepsy syndrome	8.21e-06	7.3e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR downstream signaling—PRKCB—epilepsy syndrome	8.2e-06	7.29e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—TSC1—epilepsy syndrome	8.18e-06	7.27e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—PTK2B—epilepsy syndrome	8.18e-06	7.27e-05	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—HES1—epilepsy syndrome	8.13e-06	7.22e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR downstream signaling—PRKCB—epilepsy syndrome	8.12e-06	7.22e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—PTK2B—epilepsy syndrome	8.1e-06	7.2e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—TSC1—epilepsy syndrome	8.1e-06	7.2e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—AGT—epilepsy syndrome	8.09e-06	7.19e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—AGT—epilepsy syndrome	8.06e-06	7.17e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—NTRK2—epilepsy syndrome	7.98e-06	7.1e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—SST—epilepsy syndrome	7.98e-06	7.1e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—CCR2—epilepsy syndrome	7.98e-06	7.1e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—AGT—epilepsy syndrome	7.98e-06	7.1e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—NTRK2—epilepsy syndrome	7.96e-06	7.07e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—CCR2—epilepsy syndrome	7.96e-06	7.07e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—SST—epilepsy syndrome	7.96e-06	7.07e-05	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—YWHAZ—epilepsy syndrome	7.93e-06	7.05e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—DUSP6—epilepsy syndrome	7.91e-06	7.04e-05	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—FYN—epilepsy syndrome	7.9e-06	7.02e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—DUSP6—epilepsy syndrome	7.89e-06	7.01e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—NTRK2—epilepsy syndrome	7.88e-06	7.01e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—CCR2—epilepsy syndrome	7.88e-06	7.01e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—SST—epilepsy syndrome	7.88e-06	7.01e-05	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—H2AFX—epilepsy syndrome	7.87e-06	7e-05	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—MEF2C—epilepsy syndrome	7.86e-06	6.99e-05	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—NGF—epilepsy syndrome	7.84e-06	6.97e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—ADRA2A—epilepsy syndrome	7.81e-06	6.95e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—DUSP6—epilepsy syndrome	7.81e-06	6.94e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—ADRA2A—epilepsy syndrome	7.79e-06	6.92e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—PLAT—epilepsy syndrome	7.78e-06	6.92e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—PLAT—epilepsy syndrome	7.76e-06	6.89e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—ADRA2A—epilepsy syndrome	7.71e-06	6.86e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—PLAT—epilepsy syndrome	7.68e-06	6.83e-05	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—CCR5—epilepsy syndrome	7.63e-06	6.78e-05	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—YWHAZ—epilepsy syndrome	7.6e-06	6.75e-05	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—NGF—epilepsy syndrome	7.51e-06	6.68e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—BDKRB2—epilepsy syndrome	7.51e-06	6.67e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—CXCL12—epilepsy syndrome	7.51e-06	6.67e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR downstream signaling—POMC—epilepsy syndrome	7.5e-06	6.66e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—BDKRB2—epilepsy syndrome	7.48e-06	6.65e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—CXCL12—epilepsy syndrome	7.48e-06	6.65e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—PRKCB—epilepsy syndrome	7.47e-06	6.64e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR downstream signaling—POMC—epilepsy syndrome	7.47e-06	6.64e-05	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—HTR2A—epilepsy syndrome	7.47e-06	6.64e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—PRKCB—epilepsy syndrome	7.45e-06	6.62e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—IL6ST—epilepsy syndrome	7.44e-06	6.62e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—IL6ST—epilepsy syndrome	7.42e-06	6.59e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—BDKRB2—epilepsy syndrome	7.41e-06	6.59e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—CXCL12—epilepsy syndrome	7.41e-06	6.59e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR downstream signaling—POMC—epilepsy syndrome	7.4e-06	6.58e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—PRKCB—epilepsy syndrome	7.38e-06	6.56e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—JUNB—epilepsy syndrome	7.37e-06	6.55e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—CNR1—epilepsy syndrome	7.37e-06	6.55e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—IL6ST—epilepsy syndrome	7.35e-06	6.53e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—CNR1—epilepsy syndrome	7.35e-06	6.53e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—JUNB—epilepsy syndrome	7.35e-06	6.53e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—PLCB1—epilepsy syndrome	7.34e-06	6.53e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—PLCB1—epilepsy syndrome	7.32e-06	6.51e-05	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—CCR5—epilepsy syndrome	7.31e-06	6.5e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—HMOX1—epilepsy syndrome	7.28e-06	6.47e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—JUNB—epilepsy syndrome	7.27e-06	6.47e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—CNR1—epilepsy syndrome	7.27e-06	6.47e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—PLCB1—epilepsy syndrome	7.25e-06	6.44e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—HTR7—epilepsy syndrome	7.19e-06	6.39e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—CAT—epilepsy syndrome	7.18e-06	6.38e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—HTR7—epilepsy syndrome	7.17e-06	6.37e-05	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—HTR2A—epilepsy syndrome	7.15e-06	6.36e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—HTR7—epilepsy syndrome	7.1e-06	6.31e-05	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—TSC2—epilepsy syndrome	7.09e-06	6.31e-05	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—AGT—epilepsy syndrome	7.09e-06	6.3e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—ABCB1—epilepsy syndrome	6.99e-06	6.21e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—HBEGF—epilepsy syndrome	6.98e-06	6.2e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—HBEGF—epilepsy syndrome	6.96e-06	6.18e-05	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—APOE—epilepsy syndrome	6.94e-06	6.17e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—HBEGF—epilepsy syndrome	6.89e-06	6.12e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—AKT3—epilepsy syndrome	6.85e-06	6.09e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—AKT3—epilepsy syndrome	6.83e-06	6.07e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—POMC—epilepsy syndrome	6.81e-06	6.05e-05	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—KDR—epilepsy syndrome	6.8e-06	6.05e-05	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—TSC2—epilepsy syndrome	6.79e-06	6.04e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—POMC—epilepsy syndrome	6.79e-06	6.03e-05	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—AGT—epilepsy syndrome	6.79e-06	6.03e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—AKT3—epilepsy syndrome	6.76e-06	6.01e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—POMC—epilepsy syndrome	6.72e-06	5.97e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—ADAM10—epilepsy syndrome	6.69e-06	5.95e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—ADAM10—epilepsy syndrome	6.67e-06	5.93e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—CCL2—epilepsy syndrome	6.66e-06	5.92e-05	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—APOE—epilepsy syndrome	6.65e-06	5.91e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—CCL2—epilepsy syndrome	6.64e-06	5.9e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—ADAM10—epilepsy syndrome	6.61e-06	5.87e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—CCL2—epilepsy syndrome	6.57e-06	5.84e-05	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—PRKCB—epilepsy syndrome	6.55e-06	5.82e-05	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—IL6ST—epilepsy syndrome	6.52e-06	5.8e-05	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—KDR—epilepsy syndrome	6.51e-06	5.79e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—GPX1—epilepsy syndrome	6.5e-06	5.77e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—S100B—epilepsy syndrome	6.33e-06	5.62e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—S100B—epilepsy syndrome	6.31e-06	5.61e-05	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—PRKCB—epilepsy syndrome	6.27e-06	5.57e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—SOCS3—epilepsy syndrome	6.27e-06	5.57e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—CDC42—epilepsy syndrome	6.25e-06	5.56e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—S100B—epilepsy syndrome	6.25e-06	5.55e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—SOCS3—epilepsy syndrome	6.25e-06	5.55e-05	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—IL6ST—epilepsy syndrome	6.24e-06	5.55e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—CDC42—epilepsy syndrome	6.23e-06	5.54e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—SOCS3—epilepsy syndrome	6.18e-06	5.5e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—CDC42—epilepsy syndrome	6.17e-06	5.48e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—AVP—epilepsy syndrome	6.05e-06	5.38e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—AVP—epilepsy syndrome	6.03e-06	5.36e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—AVP—epilepsy syndrome	5.97e-06	5.31e-05	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—POMC—epilepsy syndrome	5.96e-06	5.3e-05	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—CCL2—epilepsy syndrome	5.84e-06	5.19e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—HES1—epilepsy syndrome	5.72e-06	5.09e-05	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—POMC—epilepsy syndrome	5.71e-06	5.08e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—HES1—epilepsy syndrome	5.7e-06	5.07e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—AGT—epilepsy syndrome	5.7e-06	5.06e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—HES1—epilepsy syndrome	5.65e-06	5.02e-05	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—CCL2—epilepsy syndrome	5.59e-06	4.97e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—APOE—epilepsy syndrome	5.58e-06	4.96e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—FYN—epilepsy syndrome	5.56e-06	4.95e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—FYN—epilepsy syndrome	5.55e-06	4.93e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—H2AFX—epilepsy syndrome	5.54e-06	4.93e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—MEF2C—epilepsy syndrome	5.53e-06	4.92e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—H2AFX—epilepsy syndrome	5.53e-06	4.91e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—MEF2C—epilepsy syndrome	5.52e-06	4.9e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—FYN—epilepsy syndrome	5.49e-06	4.88e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—H2AFX—epilepsy syndrome	5.47e-06	4.86e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—MEF2C—epilepsy syndrome	5.46e-06	4.86e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—YWHAZ—epilepsy syndrome	5.35e-06	4.75e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—YWHAZ—epilepsy syndrome	5.33e-06	4.74e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—NGF—epilepsy syndrome	5.29e-06	4.7e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—YWHAZ—epilepsy syndrome	5.28e-06	4.69e-05	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—FGF2—epilepsy syndrome	5.27e-06	4.69e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—NGF—epilepsy syndrome	5.27e-06	4.69e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—NGF—epilepsy syndrome	5.22e-06	4.64e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—CCR5—epilepsy syndrome	5.15e-06	4.57e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—CCR5—epilepsy syndrome	5.13e-06	4.56e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—CCR5—epilepsy syndrome	5.08e-06	4.51e-05	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—FGF2—epilepsy syndrome	5.05e-06	4.49e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—HTR2A—epilepsy syndrome	5.04e-06	4.48e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—HTR2A—epilepsy syndrome	5.02e-06	4.46e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—HTR2A—epilepsy syndrome	4.97e-06	4.42e-05	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—RELA—epilepsy syndrome	4.9e-06	4.35e-05	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—MTOR—epilepsy syndrome	4.8e-06	4.27e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—POMC—epilepsy syndrome	4.79e-06	4.26e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—TSC2—epilepsy syndrome	4.78e-06	4.25e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—AGT—epilepsy syndrome	4.78e-06	4.25e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—TSC2—epilepsy syndrome	4.77e-06	4.24e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—AGT—epilepsy syndrome	4.76e-06	4.23e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—TSC2—epilepsy syndrome	4.72e-06	4.2e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—AGT—epilepsy syndrome	4.72e-06	4.19e-05	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—RELA—epilepsy syndrome	4.69e-06	4.17e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—APOE—epilepsy syndrome	4.68e-06	4.16e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—APOE—epilepsy syndrome	4.67e-06	4.15e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—APOE—epilepsy syndrome	4.62e-06	4.11e-05	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—MTOR—epilepsy syndrome	4.6e-06	4.09e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—KDR—epilepsy syndrome	4.59e-06	4.08e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—KDR—epilepsy syndrome	4.57e-06	4.06e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—KDR—epilepsy syndrome	4.53e-06	4.02e-05	CbGpPWpGaD
Glycopyrrolate—CHRM4—GPCR downstream signaling—AKT1—epilepsy syndrome	4.46e-06	3.96e-05	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—CASP3—epilepsy syndrome	4.42e-06	3.92e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—PRKCB—epilepsy syndrome	4.41e-06	3.92e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—PRKCB—epilepsy syndrome	4.4e-06	3.91e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—IL6ST—epilepsy syndrome	4.4e-06	3.91e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—IL6ST—epilepsy syndrome	4.38e-06	3.9e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—ALB—epilepsy syndrome	4.37e-06	3.88e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—PRKCB—epilepsy syndrome	4.36e-06	3.87e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—IL6ST—epilepsy syndrome	4.34e-06	3.86e-05	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—JUN—epilepsy syndrome	4.29e-06	3.81e-05	CbGpPWpGaD
Glycopyrrolate—CHRM5—GPCR downstream signaling—AKT1—epilepsy syndrome	4.27e-06	3.79e-05	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—CASP3—epilepsy syndrome	4.23e-06	3.76e-05	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—MMP9—epilepsy syndrome	4.17e-06	3.71e-05	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—JUN—epilepsy syndrome	4.11e-06	3.65e-05	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling by GPCR—AKT1—epilepsy syndrome	4.05e-06	3.6e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—POMC—epilepsy syndrome	4.02e-06	3.57e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—POMC—epilepsy syndrome	4.01e-06	3.56e-05	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—MMP9—epilepsy syndrome	4e-06	3.55e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—POMC—epilepsy syndrome	3.97e-06	3.53e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—CCL2—epilepsy syndrome	3.93e-06	3.5e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—CCL2—epilepsy syndrome	3.92e-06	3.49e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—CCL2—epilepsy syndrome	3.88e-06	3.45e-05	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling by GPCR—AKT1—epilepsy syndrome	3.88e-06	3.44e-05	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—SRC—epilepsy syndrome	3.85e-06	3.42e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—PTGS2—epilepsy syndrome	3.82e-06	3.4e-05	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—VEGFA—epilepsy syndrome	3.75e-06	3.33e-05	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—SRC—epilepsy syndrome	3.68e-06	3.27e-05	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—VEGFA—epilepsy syndrome	3.59e-06	3.19e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—FGF2—epilepsy syndrome	3.56e-06	3.16e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—FGF2—epilepsy syndrome	3.54e-06	3.15e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—FGF2—epilepsy syndrome	3.51e-06	3.12e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—RELA—epilepsy syndrome	3.3e-06	2.93e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—RELA—epilepsy syndrome	3.29e-06	2.92e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—RELA—epilepsy syndrome	3.26e-06	2.9e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—MTOR—epilepsy syndrome	3.24e-06	2.88e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—MTOR—epilepsy syndrome	3.23e-06	2.87e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—MTOR—epilepsy syndrome	3.2e-06	2.84e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR downstream signaling—AKT1—epilepsy syndrome	3.01e-06	2.67e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR downstream signaling—AKT1—epilepsy syndrome	3e-06	2.66e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—CASP3—epilepsy syndrome	2.98e-06	2.65e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—CASP3—epilepsy syndrome	2.97e-06	2.64e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR downstream signaling—AKT1—epilepsy syndrome	2.97e-06	2.64e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—CASP3—epilepsy syndrome	2.94e-06	2.61e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—JUN—epilepsy syndrome	2.89e-06	2.57e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—JUN—epilepsy syndrome	2.88e-06	2.56e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—JUN—epilepsy syndrome	2.85e-06	2.54e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—MMP9—epilepsy syndrome	2.81e-06	2.5e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—MMP9—epilepsy syndrome	2.8e-06	2.49e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—MMP9—epilepsy syndrome	2.78e-06	2.47e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—AKT1—epilepsy syndrome	2.73e-06	2.43e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—AKT1—epilepsy syndrome	2.72e-06	2.42e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—AKT1—epilepsy syndrome	2.69e-06	2.39e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—SRC—epilepsy syndrome	2.59e-06	2.31e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—SRC—epilepsy syndrome	2.59e-06	2.3e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—SRC—epilepsy syndrome	2.56e-06	2.28e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—VEGFA—epilepsy syndrome	2.53e-06	2.25e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—VEGFA—epilepsy syndrome	2.52e-06	2.24e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—VEGFA—epilepsy syndrome	2.49e-06	2.22e-05	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—AKT1—epilepsy syndrome	2.39e-06	2.13e-05	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—AKT1—epilepsy syndrome	2.29e-06	2.04e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—AKT1—epilepsy syndrome	1.92e-06	1.71e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—AKT1—epilepsy syndrome	1.61e-06	1.43e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—AKT1—epilepsy syndrome	1.61e-06	1.43e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—AKT1—epilepsy syndrome	1.59e-06	1.41e-05	CbGpPWpGaD
